Related Experiment Video
Updated: Jun 26, 2025
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Pig models for translational Duchenne muscular dystrophy research
Michael Stirm1, Nikolai Klymiuk2, Hiroshi Nagashima3
1Chair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, Ludwig Maximilian University of Munich (LMU Munich), 81377 Munich, Germany; Center for Innovative Medical Models (CiMM), LMU, Munich, 85764, Oberschleißheim, Germany; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, 81377 Munich, Germany.
Genetically engineered pigs with Duchenne muscular dystrophy (DMD) mimic human disease progression. These DMD pig models accelerate testing of gene therapies and diagnostic tools for this severe muscle-wasting condition.
Area of Science:
- Biomedical Research
- Animal Models
- Genetics
Background:
- Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disorder caused by mutations in the DMD gene, leading to dystrophin deficiency.
- This deficiency results in progressive muscle degeneration, weakness, and often fatal heart failure.
- Current therapeutic strategies face challenges in preclinical development and translation to human patients.
Purpose of the Study:
- To establish and characterize genetically engineered pig models that accurately recapitulate human DMD.
- To utilize these DMD pig models for evaluating novel therapeutic interventions and advanced diagnostic techniques.
- To bridge the gap between early-stage research and clinical application for DMD.
Main Methods:
- Development of genetically tailored pigs carrying mutations analogous to human DMD.
- Assessment of biochemical, clinical, and pathological features of DMD in the pig model.
- Application of gene editing and artificial chromosome vector delivery for therapeutic testing.
- Validation of multispectral optoacoustic tomography (MSOT) for non-invasive disease monitoring.
Main Results:
- DMD pig models exhibit accelerated disease progression compared to human patients.
- These models successfully recapitulate key hallmarks of DMD, including muscle degeneration and cardiac dysfunction.
- The models have been instrumental in evaluating gene-based therapies and diagnostic technologies.
- MSOT proved effective for non-invasive monitoring of DMD progression in pigs.
Conclusions:
- Genetically engineered DMD pigs serve as a powerful preclinical model for Duchenne muscular dystrophy.
- These models facilitate the evaluation of gene therapies and diagnostic tools, accelerating therapeutic development.
- DMD pigs offer a translational bridge from basic research to clinical trials in human patients.
